标题
Pharmacological Treatments for Patients with Treatment-Resistant Depression
作者
关键词
-
出版物
Pharmaceuticals
Volume 13, Issue 6, Pages 116
出版商
MDPI AG
发表日期
2020-06-05
DOI
10.3390/ph13060116
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study
- (2018) Mary Hobart et al. CURRENT MEDICAL RESEARCH AND OPINION
- Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial
- (2018) Verònica Gálvez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials
- (2018) Inara F. Raupp-Barcaro et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
- (2018) Deborah S. Hasin et al. JAMA Psychiatry
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Management of treatment-resistant depression in primary care: a mixed-methods study
- (2018) Nicola Wiles et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
- (2018) Yoav Domany et al. BRITISH JOURNAL OF PSYCHIATRY
- Repeat-Dose Ketamine Augmentation for Treatment-Resistant Depression with Chronic Suicidal Ideation: A Randomized, Double Blind, Placebo Controlled Trial
- (2018) Dawn F. Ionescu et al. JOURNAL OF AFFECTIVE DISORDERS
- When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips
- (2018) Manish K. Jha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
- (2018) David S Kessler et al. BMJ-British Medical Journal
- Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment
- (2017) Somaia Mohamed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression
- (2017) Charles R. Conway et al. JAMA Psychiatry
- Long-Term Impact of Residual Symptoms in Treatment-Resistant Depression
- (2017) Abebaw Fekadu et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial
- (2016) Eric J. Lenze et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants
- (2016) Robert M. Berman et al. CNS SPECTRUMS
- Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study
- (2015) George I. Papakostas et al. AMERICAN JOURNAL OF PSYCHIATRY
- Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded,prospective study
- (2015) Changsu Han et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Duloxetine-bupropion combination for treatment-resistant atypical depression: A double-blind, randomized, placebo-controlled trial
- (2014) Michele Fornaro et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder
- (2013) Michael Bauer et al. JOURNAL OF AFFECTIVE DISORDERS
- A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
- (2012) George I. Papakostas et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder
- (2012) Reiji Yoshimura et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)
- (2012) Maurizio Fava et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression
- (2011) G. Rosso et al. JOURNAL OF AFFECTIVE DISORDERS
- A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression
- (2011) James G. Barbee et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Pilot Study of the Efficacy and Safety of Paroxetine Augmented With Risperidone, Valproate, Buspirone, Trazodone, or Thyroid Hormone in Adult Chinese Patients With Treatment-Resistant Major Depression
- (2011) Yiru Fang et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study
- (2010) Nizar El-Khalili et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Comparisons of the Efficacy and Tolerability of Extended-Release Venlafaxine, Mirtazapine, and Paroxetine in Treatment-Resistant Depression
- (2010) Yiru Fang et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder
- (2009) Hollis Reeves et al. JOURNAL OF CLINICAL PSYCHIATRY
- Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder
- (2009) Michael Bauer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder
- (2009) Andrew J. Cutler et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
- (2009) Ronald N. Marcus et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression
- (2008) Gabor I. Keitner et al. JOURNAL OF PSYCHIATRIC RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More